The 18th edition came into effect on June 7, 2021, and consists of
Being an official document, it defines the specifications, criteria and standard test methods necessary to properly assure the quality of medicines in Japan. The document is revised periodically with a further edition being planned for the year 2026.
PMDA: Japanese Pharmacopoeia
> Do not hesitate, we look forward to your feedback!
Write a comment on this news.